MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6-Reference-Cited by-同舟云学术

MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6

Author:

Yang Lawei¹,Lin Ziying¹,Wang Yahong¹,Gao Shenglan¹,Li Qinglan²,Li Chunyan¹,Xu Wenya¹,Chen Jie³,Liu Tie⁴,Song Zeqing²,Liu Gang¹^ORCID

Affiliation:

1. Clinical Research Center; Guangdong Medical University; Zhanjiang 524001 China

2. Department of Respiratory Medicine; Affiliated Hospital of Guangdong Medical University; Zhanjiang 524001 China

3. Department of Cardiothoracic Surgery; Affiliated Hospital of Guangdong Medical University; Zhanjiang 524001 China

4. The First Affiliated Hospital; Medical School of Xi'an Jiaotong University; Xi'an Shanxi 710061 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference37 articles.

3. Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer;Tran;Lung Cancer (Auckl),2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献